Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Cancer Immunology Research|January 8, 2020
Tumor Antigen Heterogeneity: The "Elephant in the Room" of Adoptive T-cell Therapy for Solid TumorsSteven M Albelda
Chest|March 15, 2002
Pulmonary genetics, genomics, and gene therapy: conference summarySteven M Albelda
Cancer Immunology Research|January 13, 2026
Taking "Multiple Shots on Goal" with an Armed Invariant NK Cell ApproachSteven M Albelda
Nature Reviews. Clinical Oncology|October 31, 2023
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearnSteven M Albelda
Journal of Cellular Immunology|September 11, 2020
Current Advances in CAR T Cell Therapy for Malignant MesotheliomaAstero Klampatsa, Steven M Albelda
Cancer Discovery|December 5, 2018
Molecular Characterization of Malignant Mesothelioma: Time for New Targets?Charu Aggarwal, Steven M Albelda
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
Giving oncolytic vaccinia virus more BiTESteven M Albelda, Steve H Thorne
Translational Lung Cancer Research|May 13, 2024
Small cell, big promises: targeting small cell lung cancer with CAR T cellsEstela Noguera-Ortega, Steven M Albelda
Oncoimmunology|February 6, 2014
Modifying tumor-associated macrophages: An important adjunct to immunotherapyZvi G Fridlender, Steven M Albelda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
TNFerade to the rescue? Guidelines for evaluating phase I cancer gene transfer trialsSteven M Albelda, Daniel H Sterman
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Cancer Immunology Research|January 8, 2020
Tumor Antigen Heterogeneity: The "Elephant in the Room" of Adoptive T-cell Therapy for Solid TumorsSteven M Albelda
Chest|March 15, 2002
Pulmonary genetics, genomics, and gene therapy: conference summarySteven M Albelda
Cancer Immunology Research|January 13, 2026
Taking "Multiple Shots on Goal" with an Armed Invariant NK Cell ApproachSteven M Albelda
Nature Reviews. Clinical Oncology|October 31, 2023
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearnSteven M Albelda
Journal of Cellular Immunology|September 11, 2020
Current Advances in CAR T Cell Therapy for Malignant MesotheliomaAstero Klampatsa, Steven M Albelda
Cancer Discovery|December 5, 2018
Molecular Characterization of Malignant Mesothelioma: Time for New Targets?Charu Aggarwal, Steven M Albelda
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
Giving oncolytic vaccinia virus more BiTESteven M Albelda, Steve H Thorne
Translational Lung Cancer Research|May 13, 2024
Small cell, big promises: targeting small cell lung cancer with CAR T cellsEstela Noguera-Ortega, Steven M Albelda
Oncoimmunology|February 6, 2014
Modifying tumor-associated macrophages: An important adjunct to immunotherapyZvi G Fridlender, Steven M Albelda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
TNFerade to the rescue? Guidelines for evaluating phase I cancer gene transfer trialsSteven M Albelda, Daniel H Sterman
Pageof 20